Drug Shortage Report for NAT-QUETIAPINE

Last updated on 2021-10-31 History
Report ID 82236
Drug Identification Number 02439174
Brand name NAT-QUETIAPINE
Common or Proper name Quetiapine Fumarate
Company Name NATCO PHARMA (CANADA) INC
Market Status MARKETED
Active Ingredient(s) QUETIAPINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2019-04-23
Actual start date 2019-04-23
Estimated end date
Actual end date 2021-10-30
Shortage status Resolved
Updated date 2021-10-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5N 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-10-31 French Compare
v6 2021-10-14 English Compare
v5 2019-06-17 French Compare
v4 2019-06-17 English Compare
v3 2019-04-23 English Compare
v2 2019-04-23 English Compare
v1 2019-04-23 English Compare

Showing 1 to 7 of 7